Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Blood|July 15, 2004
Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pumpHerman Burger, Hans van Tol, Antonius W M Boersma, et al.
Ophthalmology|April 25, 2006
Late-onset retinoblastoma in a well-functioning fellow eyePaulus T V M de Jong, Cornelia M Mooy, Gerrit Stoter, et al.
Pharmacy World & Science : PWS|March 29, 2003
Neuropsychiatric side effects of interferon-alfa therapyArthur R Van Gool, Wim H J Kruit, Frederike K Engels, et al.
Anti-Cancer Drugs|March 14, 2003
Red blood cells: a neglected compartment in topotecan pharmacokinetic analysisWalter J Loos, Hans Gelderblom, Jaap Verweij, et al.
European Journal of Cancer (Oxford, England : 1990)|February 10, 2009
A systematic review on barriers hindering adequate cancer pain management and interventions to reduce them: a critical appraisalWendy H Oldenmenger, Peter A E Sillevis Smitt, Silvia van Dooren, et al.
Cancer Biology & Therapy|June 16, 2006
Impaired cisplatin influx in an A2780 mutant cell line: evidence for a putative, cis-configuration-specific, platinum influx transporterJozien Helleman, Herman Burger, Irene H L Hamelers, et al.
Neoplasia (New York, N.Y.)|July 17, 2004
Resistance to platinum-containing chemotherapy in testicular germ cell tumors is associated with downregulation of the protein kinase SRPK1Paul W Schenk, Hans Stoop, Carsten Bokemeyer, et al.
Molecular Pharmacology|July 19, 2003
Anticancer drug resistance induced by disruption of the Saccharomyces cerevisiae NPR2 gene: a novel component involved in cisplatin- and doxorubicin-provoked cell killPaul W Schenk, Mariel Brok, Antonius W M Boersma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2004
A phase I and pharmacokinetic study of weekly paclitaxel and carboplatin in patients with metastatic esophageal cancerMarco B Polee, Alex Sparreboom, Ferry A L M Eskens, et al.
Anti-Cancer Drugs|August 21, 2002
Preclinical evaluation of alternative pharmaceutical delivery vehicles for paclitaxelWalter J Loos, Janos Szebeni, Albert J ten Tije, et al.
Pageof 4